Weiwei Chen
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Shaohui Tang (9 shared papers)Yan Zhang (1 shared paper)Xin‐Yuan Guan (1 shared paper)Liliangzi Guo (6 shared papers)Shaowei Dong (1 shared paper)Bo Li (1 shared paper)Liangliang Xu (1 shared paper)Cai‐Ning Zhao (2 shared papers)
- Journals
- Frontiers in Oncology (2 papers)World Journal of Surgical Oncology (2 papers)Gene (1 paper)The Journal of Rheumatology (1 paper)Frontiers in Nutrition (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weiwei Chen
41 papers receiving 469 citations
Peers
Comparison fields: 5 of 87
- Oncology 178
- Immunology 94
- Cancer Research 40
- Nephrology 13
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Weiwei Chen
This map shows the geographic impact of Weiwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Chen more than expected).
Fields of papers citing papers by Weiwei Chen
This network shows the impact of papers produced by Weiwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Chen. The network helps show where Weiwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 128 | |
| 2 | 2024 | 39 | |
| 3 | 2012 | 29 | |
| 4 | 2019 | 28 | |
| 5 | 2014 | 24 | |
| 6 | 2022 | 20 | |
| 7 | 2022 | 19 | |
| 8 | 2017 | 18 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 12 | |
| 11 | 2019 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2018 | 10 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2018 | 6 |
About Weiwei Chen
Weiwei Chen is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 474 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Screening and Detection (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Oncology (178 citations), Immunology (94 citations), Cancer Research (40 citations), Nephrology (13 citations) and Pulmonary and Respiratory Medicine (46 citations). Weiwei Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shaohui Tang, Yan Zhang, Xin‐Yuan Guan, Liliangzi Guo, Shaowei Dong, Bo Li, Liangliang Xu, Cai‐Ning Zhao, Feng‐Ming Kong and Zhiyuan Xu. Their work appears in journals such as Frontiers in Oncology, World Journal of Surgical Oncology, Gene, The Journal of Rheumatology and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.